Concord Biotech Ltd Financials

As of 23 Oct 2026 at 15:54, Concord Biotech Ltd is trading at ₹1,229.30. The 52-week range stands at ₹987.00–₹1,615.00, with a market cap of ₹12.86 thousand crore. At a P/E of 45.21 and a dividend yield of 0.61%, it is a mid-cap stock in the Pharmaceuticals sector.